Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 125496181 | 12549618 | 1 | I | 2014 | 20160708 | 20160712 | 20160712 | PER | US-PFIZER INC-2016337619 | PFIZER | 65.00 | YR | F | Y | 86.00000 | KG | 20160712 | CN | US | US |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 125496181 | 12549618 | 1 | PS | ALPRAZOLAM. | ALPRAZOLAM | 1 | Oral | 1.5 MG, 3X/DAY | 18276 | 1.5 | MG | TABLET | TID | ||||||
| 125496181 | 12549618 | 2 | C | ATACAND | CANDESARTAN CILEXETIL | 1 | Oral | 32 MG, DAILY | 0 | 32 | MG | TABLET |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 125496181 | 12549618 | 1 | Anxiety |
| 125496181 | 12549618 | 2 | Blood pressure abnormal |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 125496181 | 12549618 | HO |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 125496181 | 12549618 | Incorrect dose administered | |
| 125496181 | 12549618 | Seizure |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| no results found |